(Q46120030)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19451064%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

title

Characteristics and outcome of prostate cancer with PSA <4 ng/ml at diagnosis: a population-based study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19451064%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19451064%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

author name string

A Merglen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19451064%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

G Fioretta

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19451064%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

E Rapiti

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19451064%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

I Neyroud-Caspar

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19451064%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

R Zanetti

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19451064%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

R Miralbell

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19451064%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

C Bouchardy

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19451064%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

publication date

1 May 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19451064%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Translational Oncology

28 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19451064%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19451064%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

page(s)

312-317

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19451064%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19451064%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s12094-009-0359-1

28 January 2020

exact match

0 references

cites work

Cancer Detection and Cancer Characteristics in the European Randomized Study of Screening for Prostate Cancer (ERSPC) – Section Rotterdam

1 reference

12 December 2020

The importance of marital and socioeconomic status in incidence and survival of prostate cancer. An analysis of complete Norwegian birth cohorts

1 reference

12 December 2020

Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer

1 reference

12 December 2020

Radiation therapy for T1 and T2 prostate cancer: prostate-specific antigen and disease outcome

1 reference

12 December 2020

Influence of age and prostate-specific antigen on the chance of curable prostate cancer among men with nonpalpable disease

1 reference

12 December 2020

Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter

1 reference

12 December 2020

Lower prostate specific antigen outcome than expected following radical prostatectomy in patients with high grade prostate and a prostatic specific antigen level of 4 ng/ml. Or less

1 reference

12 December 2020

Survival in prostate carcinoma--outcomes from a prospective, population-based cohort of 8887 men with up to 15 years of follow-up: results from three countries in the population-based National Prostate Cancer Registry of Sweden

1 reference

12 December 2020

Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements

1 reference

12 December 2020

Preoperative PSA and progression-free survival after radical prostatectomy for Stage T1c disease

1 reference

12 December 2020

Biopsy of men with PSA level of 2.6 to 4.0 ng/mL associated with favorable pathologic features and PSA progression rate: a preliminary analysis.

1 reference

12 December 2020

Impact of socioeconomic status and race on clinical parameters of patients undergoing radical prostatectomy in an equal access health care system.

1 reference

12 December 2020

Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia

1 reference

12 December 2020

Identifying men diagnosed with clinically localized prostate cancer who are at high risk for death from prostate cancer

1 reference

12 December 2020

Prostate cancer detection in the prostate specific antigen range of 2.0 to 3.9 ng/ml: value of percent free prostate specific antigen on tumor detection and tumor aggressiveness.

1 reference

12 December 2020

Histological characteristics of radical prostatectomy specimens in men with a serum prostate specific antigen of 4 ng./ml or less

1 reference

12 December 2020

1 reference

12 December 2020

Preoperative serum prostate specific antigen levels between 2 and 22 ng./ml. correlate poorly with post-radical prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9 ng./ml

1 reference

12 December 2020

Biochemical outcome after radical prostatectomy among men with normal preoperative serum prostate-specific antigen levels.

1 reference

12 December 2020

Prostate-specific antigen to predict outcome of external beam radiation for prostate cancer: Walter Reed Army Medical Center experience, 1988-1995

1 reference

12 December 2020

Racial differences in screening for prostate cancer in the elderly.

1 reference

12 December 2020

Performance of a neural network in detecting prostate cancer in the prostate-specific antigen reflex range of 2.5 to 4.0 ng/mL.

1 reference

12 December 2020

The incidence of prostate cancer in a screening population with a serum prostate specific antigen between 2.5 and 4.0 ng/ml: relation to biopsy strategy

1 reference

12 December 2020

The impact of socioeconomic status on survival after cancer in the United States : findings from the National Program of Cancer Registries Patterns of Care Study

1 reference

12 December 2020

Characteristics of screening detected prostate cancer in men 50 to 66 years old with 3 to 4 ng./ml. Prostate specific antigen

1 reference

12 December 2020

Pathological outcomes and biochemical progression in men with T1c prostate cancer undergoing radical prostatectomy with prostate specific antigen 2.6 to 4.0 vs 4.1 to 6.0 ng/ml

1 reference

12 December 2020

Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years

1 reference

12 December 2020

Prostate-specific antigen as a marker of disease activity in prostate cancer.

1 reference

12 December 2020

Early detection of prostate cancer with low PSA cut-off values leads to significant stage migration in radical prostatectomy specimens.

1 reference

12 December 2020

Prostate cancer detection at low prostate specific antigen

1 reference

12 December 2020

Impact of preoperative serum PSA level from 0 to 10 ng/ml on pathological findings and disease-free survival after radical prostatectomy

1 reference

12 December 2020

Prostate-specific antigen cutoff of 2.6 ng/mL for prostate cancer screening is associated with favorable pathologic tumor features

1 reference

12 December 2020

Prostate cancer: demographic and behavioral correlates of stage at diagnosis among blacks and whites in North Carolina

1 reference

12 December 2020

Prostate cancer detection among men with prostate specific antigen levels of 2.5 to 4.0 ng/ml in a Japanese urological referral population

1 reference

12 December 2020

10.1007/S12094-009-0359-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19451064%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference